Clinical trials expand—while cyber-zero-days surge
LISTEN
Direct audio file (MP3)The world’s active gene, cell, mRNA and SI clinical trial pipeline keeps widening (21,542 trials on ClinicalTrials.gov), with 29 new Wire signals and 13 new Cure research signals added in the last 24 hours. In parallel, an AI-fueled scan reported 28 zero-days in 48 hours across Physical AI software—targets include projects maintained by major AI firms—underscoring that the AI phase transition is moving faster than the defenses. Funding and governance signals echo the same transition pressure: the IMF flagged AI-linked circular financing topping $1T, with roughly two-thirds structured as debt, even as policy actors push for faster resilience against cyber, sabotage, and climate compounding threats. These are not cure events by themselves, but they shape the tempo and survivability of the systems that will carry cures forward. The window is still open.
VicOne reports finding 28 zero-days in under two days using AI-assisted research.
If rapid Physical AI exploitation outpaces hardening, humanity pays in lost trust, disrupted deployment, and slowed downstream medical translation—while resilient infrastructures let cure pipelines compound.
Watch for concrete hardening responses to the 28-zero-day findings and act on them now—because the threat stack is compounding while research and funding accelerate.